Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Review article: breath testing for human liver function assessment.

A Armuzzi1, M Candelli, M A Zocco

  • 1Department of Internal Medicine, Catholic University, Rome, Italy.

Alimentary Pharmacology & Therapeutics
|November 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC).

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2025
Same author

Rate of change in upper and lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis.

Journal of neurology·2025
Same author

The Impact of Ustekinumab Biosimilar on Therapeutic Strategies in Crohn's Disease: A Paradigm Shift?

United European gastroenterology journal·2024
Same author

Improved detection of coronary artery disease by CZT regional coronary blood flow evaluation.

Frontiers in nuclear medicine·2024
Same author

A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium.

ESMO open·2024
Same author

Bioelectrical impedance analysis in patients with posterior vitreous detachment.

European review for medical and pharmacological sciences·2023
Same journal

Letter on: Pre-Emptive Initiation of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema Improves Outcomes: A Randomized Controlled Trial.

Alimentary pharmacology & therapeutics·2026
Same journal

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same journal

Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.

Alimentary pharmacology & therapeutics·2026
Same journal

Elobixibat Versus Prucalopride in Functional Constipation: A Prospective Comparative Effectiveness Study.

Alimentary pharmacology & therapeutics·2026
Same journal

A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection.

Alimentary pharmacology & therapeutics·2026
Same journal

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy.

Alimentary pharmacology & therapeutics·2026
See all related articles

Carbon-labelled breath tests offer insights into liver function but aren't routine. This review examines their development and potential for diagnosing liver disease and monitoring treatment outcomes.

Area of Science:

  • Hepatology
  • Medical Diagnostics
  • Biochemistry

Background:

  • Carbon-labelled breath tests were introduced 30 years ago for assessing human liver function.
  • Despite their potential, these tests have not become standard clinical practice due to the liver's complex metabolic role.

Purpose of the Study:

  • To review the progress and current status of carbon-labelled breath tests for evaluating liver function.
  • To discuss the challenges and future directions for these diagnostic tools in hepatology.

Main Methods:

  • The review synthesizes data on various breath tests targeting different liver metabolic pathways (microsomal, cytosolic, mitochondrial).
  • It analyzes existing studies, focusing on data from microsomal function tests, while noting limitations in cytosolic and mitochondrial assessments.

Related Experiment Videos

Main Results:

  • Breath tests have shown promise in predicting outcomes for chronic liver disease patients.
  • They can also be valuable for monitoring liver function post-treatment.

Conclusions:

  • A single breath test cannot fully capture the liver's metabolic complexity.
  • Further research with new substrates and large prospective studies is needed to validate available compounds and establish clinical utility.